Daniel S. Chapple

1.5k total citations · 1 hit paper
8 papers, 1.3k citations indexed

About

Daniel S. Chapple is a scholar working on Infectious Diseases, Molecular Biology and Microbiology. According to data from OpenAlex, Daniel S. Chapple has authored 8 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Microbiology. Recurrent topics in Daniel S. Chapple's work include Antimicrobial Peptides and Activities (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Biochemical and Structural Characterization (3 papers). Daniel S. Chapple is often cited by papers focused on Antimicrobial Peptides and Activities (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Biochemical and Structural Characterization (3 papers). Daniel S. Chapple collaborates with scholars based in United Kingdom, Brazil and Canada. Daniel S. Chapple's co-authors include Robert E. W. Hancock, Robert W. Evans, Edward Odell, Christopher L. Joannou, David Mason, Vanya Gant, R. Sarra, Giuliano Siligardi, Rohanah Hussain and Shamez Ladhani and has published in prestigious journals such as FEBS Letters, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Daniel S. Chapple

8 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peptide Antibiotics

1999 1.0k citations Robert E. W. Hancock, Daniel S. Chapple Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Daniel S. Chapple

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Chapple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Chapple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Chapple more than expected).

Fields of papers citing papers by Daniel S. Chapple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Chapple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Chapple. The network helps show where Daniel S. Chapple may publish in the future.

Co-authorship network of co-authors of Daniel S. Chapple

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Chapple. A scholar is included among the top collaborators of Daniel S. Chapple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Chapple. Daniel S. Chapple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Structure and Association of Human Lactoferrin Peptides withEscherichia coliLipopolysaccharide 2004 ·Antimicrobial Agents and Chemotherapy ·Daniel S. Chapple, Rohanah Hussain, Christopher L. Joannou, Robert E. W. Hancock, Edward Odell, Robert W. Evans, Giuliano Siligardi	61
2	2003 ·The Pediatric Infectious Disease Journal ·Shamez Ladhani, Scott Robbie, Daniel S. Chapple, Christopher L. Joannou, Robert H. Evans	4
3	ISOLATING STAPHYLOCOCCUS AUREUS FROM CHILDREN WITH SUSPECTED STAPHYLOCOCCAL SCALDED SKIN SYNDROME IS NOT CLINICALLY USEFUL 2003 ·The Pediatric Infectious Disease Journal ·Shamez Ladhani, Scott Robbie, Daniel S. Chapple, Christopher L. Joannou, Robert W. Evans	4
4	A novel method for rapid production and purification of exfoliative toxin A ofStaphylococcus aureus 2002 ·FEMS Microbiology Letters ·Shamez Ladhani, (unknown), Daniel S. Chapple, Richard Charles Garratt, Christopher L. Joannou, Robert W. Evans	3
5	Development and Evaluation of Detection Systems for Staphylococcal Exfoliative Toxin A Responsible for Scalded-Skin Syndrome 2001 ·Journal of Clinical Microbiology ·Shamez Ladhani, Scott Robbie, Richard Charles Garratt, Daniel S. Chapple, Christopher L. Joannou, Robert W. Evans	27
6	Peptide Antibiotics breakdown → 1999 ·Antimicrobial Agents and Chemotherapy ·Robert E. W. Hancock, Daniel S. Chapple	1038
7	Structure-Function Relationship of Antibacterial Synthetic Peptides Homologous to a Helical Surface Region on Human Lactoferrin against Escherichia coli Serotype O111 1998 ·Infection and Immunity ·Daniel S. Chapple, David Mason, Christopher L. Joannou, Edward Odell, Vanya Gant, Robert W. Evans	97
8	Antibacterial activity of peptides homologous to a loop region in human lactoferrin 1996 ·FEBS Letters ·Edward Odell, R. Sarra, (unknown), Daniel S. Chapple, Robert W. Evans	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact